Table 3.

Univariate analysis of survival predictors

Variable	Median			P-value
	Estimate	SE	95% CI
Age, years
<60	24.000	2.726	18.657–29.343	0.092
≥60	18.000	0.663	16.700–19.300
Gender
Female	32.000	11.429	9.600–54.400	0.393
Male	22.000	2.498	17.103–26.897
Body mass index
<30	18.000	3.350	11.434–24.566	0.015
>30	48.000	12.565	23.374–72.626
Tumour stage
T1	48.000	0.000		0.025
T2	26.000	10.241	5.928–46.072
T3	18.000	3.318	11.496–24.504
Multifocality
No	32.000	6.480	19.299–44.701	0.013
Yes	17.000	3.536	10.070–23.930
Vascular invasion by radiological characteristics
No	23.000	3.026	17.069–28.931	0.679
Yes	12.000	8.500	0.000–28.660
Presence of ≥3 tumours
No	32.000	7.433	17.431–46.569	0.047
Yes	18.000	4.629	8.927–27.073
Single lobe vs. bilobar disease
Single lobe disease	32.000	4.849	22.497–41.503	0.030
Bilobar	17.000	3.118	10.889–23.111
Model for End-stage Liver Disease (MELD) score ≥10
No	22.000	2.676	16.754–27.246	0.228
Yes	13.000	5.233	2.743–23.257
Serum alpha-fetoprotein (AFP) ≥100 mg/ml
No	24.000	8.039	8.243–39.757	0.250
Yes	22.000	3.262	15.607–28.393

SE, standard error; 95% CI, 95% confidence interval.